LIN vs OTLK · P/E 34, rev $18.07B vs P/E 0.4, rev $1.5M
Linde plc Ordinary Shares (LIN) versus OUTLOOK THERAPEUTICS INC (OTLK) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
OUTLOOK THERAPEUTICS INC (OTLK) is a biotechnology company listed on US.
Latest reported LIN revenue for 2026-06-30 was $18.07B. Net income was $3.79B. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported OTLK revenue for 2025-06-30 was $1.5M. Net income was -$20.2M. OTLK currently screens at market cap $68.6M and trailing P/E 0.4.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. OTLK currently screens at market cap $68.6M and trailing P/E 0.4.
Not investment advice. Open the LIN and OTLK stock pages for the full models.
Not investment advice.